1 week Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily X
1 week Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity ShotInvestor's Business Daily X
3 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X
3 weeks Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen.Investor's Business Daily X
4 weeks Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The ListSeeking Alpha X
4 weeks Allspring Global Investments Holdings LLC Sells 11,091 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X